What is Alzheimer Disease?

With an aging global population, it is not surprising the focus of attention has been placed squarely on the shoulders of Alzheimer’s disease. Currently affecting 10 percent of people over 65, Alzheimer’s is a disease that causes a steady decline in memory with diagnosis now approximately 87 – 94 percent accurate.
Although discovered just over a century ago by Alois Alzheimer a German Physician, it is only during the last 30 years that this disease has started to have more research carried out. According to studies, it is advancing age that is the greatest risk to developing Alzheimer’s disease. The problem of early diagnosis is often down to the sufferer, who refuses to admit that anything is wrong even when they start to experience some of the symptoms.
At the moment all forms of dementia treatment are pretty much the same and that includes Alzheimer’s disease. Unfortunately, because there is still so much that is unknown about the disease, there is no definite way to treat it although some symptoms can be improved or slowed down with drugs. Donepezil, Tacrine, and Rivastigmine are three drugs that have been approved for use in treating Alzheimer’s by the Food and Drug Administration.
This new drug is used on patients with moderate to severe Alzheimer’s already receiving Donepezil. Memantine is the first drug to show such positive results with sufferers who have moderate to severe symptoms.
Alzheimer’s disease has become a major issue as it is already the fourth largest killer in the United States. It is not just the human cost of Alzheimer’s that has to be taken into consideration, there is also the monetary costs. Over 300 different compounds are already at various stages of development for its treatment.
The only way to improve the risk of not developing dementia is to adjust the way you live and adopt a healthier lifestyle. Researchers believe that a person suffering with Alzheimer’s who maintains their health and happiness slows down the deteriorating effects. There have been incidents where a younger person has contracted the disease but it is hoped these will not start to increase.
